Clinical Research Directory
Browse clinical research sites, groups, and studies.
Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus
Sponsor: Maasstad Hospital
Summary
Metformin vs Control to prevent gestational diabetes mellitus (GDM) in women with a high risk for GDM, an open label randomized controlled trial' The Medico-GDM trial
Official title: Metformin vs Control to Prevent Gestational Diabetes Mellitus (GDM) in Women With a High Risk for GDM, an Open Label Randomized Controlled Trial, The Medico-GDM Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2014-10-08
Completion Date
2017-03-03
Last Updated
2026-10-09
Healthy Volunteers
Yes
Conditions
Interventions
Metformin
Metformin twice daily 500 mg for the first week, after that twice daily 1000 mg (from 14 weeks pregnancy untill delivery)
control diet
2000 calories/day diet, with an adequate distribution of carbohydrates during the day
Locations (1)
Maasstad Ziekenhuis
Rotterdam, Netherlands